Abstract: The present disclosure provides CRISPR/Cas9 ribonucleoprotein compositions comprising chemically modified CRISPR RNA (crRNA) guide and trans-acting CRISPR RNA (tracrRNA) components. Methods of using the disclosed CRISPR/Cas9 ribonucleoprotein compositions are also provided.
Type:
Application
Filed:
September 22, 2017
Publication date:
June 20, 2019
Applicants:
Board of Trustees of Southern lllinois University, The Royal Institution for the Advancement of Learning/McGill University
Inventors:
Keith GAGNON, Masad DAMHA, Elise MALEK-ADAMIAN, Maryam HABIBIAN, Daniel O'REILLY, Zachery KARTJE